US Broker Ratings

Nurix Therapeutics, Inc. (NRIX) Stock Analysis: Exploring a 46.75% Potential Upside in the Biotech Sector

Nurix Therapeutics, Inc. (NRIX), a San Francisco-based clinical-stage biopharmaceutical company, is capturing investor attention with its robust pipeline and strategic partnerships in the biotechnology sector. With a market capitalization of..

Beta Bionics, Inc. (BBNX) Stock Analysis: A Promising Growth Story with 63.10% Revenue Surge

Beta Bionics, Inc. (NASDAQ: BBNX) stands at the forefront of innovation in the healthcare sector, specifically within the medical devices industry. With a market capitalization of $1.37 billion, this U.S.-based..

Oculis Holding AG (OCS) Stock Analysis: Eyeing a 117% Upside in Healthcare Innovation

Oculis Holding AG (NASDAQ: OCS), a burgeoning name in the biotechnology sector, is capturing investor attention with its promising pipeline of ophthalmic treatments and a compelling potential upside of 117.83%...

Enliven Therapeutics, Inc. (ELVN) Stock Analysis: A Biotech Powerhouse with 147% Potential Upside

Enliven Therapeutics, Inc. (NASDAQ: ELVN), a burgeoning player in the biotechnology sector, is capturing attention with its promising pipeline and significant growth potential. Based in Boulder, Colorado, this clinical-stage biopharmaceutical..

STAAR Surgical Company (STAA) Stock Analysis: Navigating Growth in the Medical Instruments Space

STAAR Surgical Company (NASDAQ: STAA) is a prominent player in the healthcare sector, specifically within the medical instruments and supplies industry. Headquartered in Lake Forest, California, the company specializes in..

Cronos Group Inc. (CRON) Stock Analysis: Navigating a Challenging Market with a 6.1% Revenue Growth

Cronos Group Inc. (NASDAQ: CRON), a prominent player in the healthcare sector specializing in cannabinoid products, finds itself at a pivotal moment. With a current market capitalization of $1.05 billion,..

Zymeworks Inc. (ZYME) Stock Analysis: Unveiling a 32% Upside Potential Amidst Robust Revenue Growth

Zymeworks Inc. (NASDAQ: ZYME), a clinical-stage biotechnology firm, is making waves in the healthcare sector with its focus on developing innovative biotherapeutics for cancer and autoimmune diseases. With a market..

Phibro Animal Health Corporation (PAHC) Stock Analysis: Navigating a 13.94% Upside in the Healthcare Sector

Phibro Animal Health Corporation (NASDAQ: PAHC), a stalwart in the healthcare sector, stands out with its diverse portfolio in animal health and mineral nutrition. With a market capitalization of $1.53..

Nuvation Bio Inc. (NUVB) Investor Outlook: A 1,704% Revenue Growth Story with an 18% Upside Potential

Nuvation Bio Inc. (NASDAQ: NUVB), a promising name in the biotechnology sector, has been capturing investor interest with its remarkable financial metrics and ambitious oncology-focused pipeline. With a market capitalization..

Avadel Pharmaceuticals plc (AVDL): Navigating a Tightrope with a 54.9% Revenue Growth and Investor Caution

Avadel Pharmaceuticals plc (AVDL) is capturing the attention of investors with its impressive 54.9% revenue growth. Operating from Dublin, Ireland, this biopharmaceutical company is making waves in the healthcare sector,..

Pharvaris N.V. (PHVS): An Investor Outlook with a Promising 79% Upside

Pharvaris N.V. (PHVS), a Swiss biopharmaceutical company, is making waves in the healthcare sector with its innovative approach to treating rare diseases. With a focus on bradykinin-mediated conditions such as..

HealthStream, Inc. (HSTM) Stock Analysis: Exploring a 42.68% Potential Upside Amid Healthcare SaaS Growth

HealthStream, Inc. (NASDAQ: HSTM), a key player in the health information services industry, presents an intriguing opportunity for investors amid a robust healthcare sector. Headquartered in Nashville, Tennessee, HealthStream specializes..

AMN Healthcare Services Inc (AMN): Investor Outlook with 27.6% Potential Upside

For investors eyeing opportunities within the healthcare sector, AMN Healthcare Services Inc (NYSE: AMN) presents a compelling case. As a leading provider of technology-enabled healthcare workforce solutions, AMN has positioned..

Arcus Biosciences, Inc. (RCUS) Stock Analysis: Navigating the 38.84% Upside Potential in the Biotech Arena

Arcus Biosciences, Inc. (NASDAQ: RCUS), a trailblazer in the biotech sector, is captivating investor interest with its promising pipeline of cancer therapies and a notable potential upside of 38.84%. As..

Ardelyx, Inc. (ARDX) Stock Analysis: Unpacking a 95% Potential Upside for Investors

Ardelyx, Inc. (NASDAQ: ARDX) is making waves in the biotechnology sector with its innovative approach to addressing unmet medical needs. With a robust market capitalization of $1.46 billion, Ardelyx’s current..

Intellia Therapeutics (NTLA) Stock Analysis: Assessing a 133.91% Potential Upside in the Biotech Arena

Intellia Therapeutics, Inc. (NASDAQ: NTLA) stands at the forefront of the biotechnology sector, captivating investor attention with its groundbreaking work in gene editing. With a market capitalization of $1.11 billion,..

DoubleVerify Holdings, Inc. (DV): Investor Outlook with a 22.65% Potential Upside

DoubleVerify Holdings, Inc. (NYSE: DV), a leading player in the advertising agencies sector, presents a compelling case for investors seeking growth in the Communication Services sector. With its innovative media..

SAP SE (SAP) Stock Analysis: A 38% Upside Potential Amid Strong Analyst Ratings

SAP SE (SAP), a titan in the technology sector and a leader in the Software – Application industry, continues to capture the attention of investors worldwide. With a robust market..

Alarm.com Holdings, Inc. (ALRM) Stock Analysis: Unveiling a 28.64% Potential Upside in the IoT Market

Alarm.com Holdings, Inc. (NASDAQ: ALRM) stands at the forefront of the Internet of Things (IoT) industry, offering comprehensive solutions for both residential and commercial markets. With a current market capitalization..

Intapp, Inc. (INTA) Stock Analysis: Exploring a 21.59% Upside Potential in the Tech-Driven Software Sector

Intapp, Inc. (NASDAQ: INTA), a leading player in the technology sector, offers a suite of AI-powered solutions designed to enhance efficiency and decision-making across various professional services industries. With its..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds